Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -24.46-22.972.447.39-57.36

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -24.46 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-24.46
Mar2023-22.97
Mar20222.44
Mar20217.39
Mar2020-57.36

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44
-66.98
Mar2021 7.39
Positive
Mar2020 -57.36 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹217.2 Cr -15.8% -17.6% -23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,893.0 Cr 1% 4.8% -13.5% Stock Analytics
DIVIS LABORATORIES ₹171,976.0 Cr 11.2% 7.4% 10.5% Stock Analytics
CIPLA ₹126,137.0 Cr 3.2% -0.1% -7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,712.0 Cr 0.3% -1.6% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹105,562.0 Cr 1.3% -3% -6.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-15.8%

-17.6%

-23.5%

SENSEX

1.6%

1.7%

1.8%


You may also like the below Video Courses